XML 29 R19.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Reporting
 9 Months Ended
Sep. 30, 2025
Segment Reporting  
Segment Reporting

12.  Segment Reporting

We report segment information based on the various industries in which our businesses operate and how we manage those businesses in accordance with our investment strategies, which may include: identifying and acquiring undervalued assets and businesses, often through the purchase of distressed securities; increasing value through management, financial or other operational changes; and managing complex legal, regulatory or financial issues, which may include bankruptcy or insolvency, environmental, zoning, permitting and licensing issues. Therefore, although many of our businesses are operated under separate local management, certain of our businesses are grouped together when they operate within a similar industry, comprising similarities in products, customers, production processes and regulatory environments, and when such businesses, when considered together, may be managed in accordance with one or more investment strategies specific to those businesses.

Our reportable segments reflect the way the Company is managed, and for which separate financial information is available and evaluated regularly by the Company’s Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources and assess performance. The Chairman of the Board of Directors of our general partner, who is our CODM, reviews financial information for each segment and evaluates the results in relation to our broader business strategies. Accordingly, segment operating results are assessed based on net income from continuing operations attributable to Icahn Enterprises. Assets provided to the CODM are consistent with those reported in the condensed consolidated balance sheets, and there are no intra-entity sales or transfers, or significant expense categories regularly reviewed by the CODM beyond those disclosed in the condensed consolidated statements of operations.

​

Condensed Statements of Operations

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 2025

​

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

​

​

(in millions)

Revenues:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net sales

​

$

—

​

$

1,945

​

$

218

​

$

91

​

$

—

​

$

42

​

$

20

​

$

—

​

$

2,316

Other revenues from operations

 

​

—

 

​

—

 

​

156

 

​

—

 

​

10

 

​

—

 

​

2

 

​

—

 

​

168

Net loss from investment activities

 

​

(48)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(48)

Interest and dividend income

 

​

47

 

​

7

 

​

—

 

​

—

 

​

2

 

​

—

 

​

—

 

​

14

 

​

70

(Loss) gain on disposition of assets, net

 

​

—

 

​

(4)

 

​

(1)

 

​

—

 

​

223

 

​

—

 

​

—

 

​

—

 

​

218

Other income (loss), net

 

​

—

 

​

—

 

​

—

 

​

1

 

​

(2)

 

​

—

 

​

1

 

​

1

 

​

1

​

 

​

(1)

 

​

1,948

 

​

373

 

​

92

 

​

233

 

​

42

 

​

23

 

​

15

 

​

2,725

Expenses:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cost of goods sold

 

​

—

 

​

1,395

 

​

155

 

​

86

 

​

—

 

​

35

 

​

14

 

​

—

 

​

1,685

Other expenses from operations

 

​

—

 

​

—

 

​

139

 

​

—

 

​

11

 

​

—

 

​

—

 

​

—

 

​

150

Dividend expense

 

​

10

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

10

Selling, general and administrative

 

​

5

 

​

50

 

​

112

 

​

14

 

​

5

 

​

12

 

​

12

 

​

8

 

​

218

Restructuring, net

​

​

—

​

​

—

​

​

—

​

​

2

​

​

—

​

​

—

​

​

—

​

​

—

​

​

2

Interest expense

 

​

4

 

​

30

 

​

—

 

​

2

 

​

—

 

​

—

 

​

—

 

​

86

 

​

122

​

 

​

19

 

​

1,475

 

​

406

 

​

104

 

​

16

 

​

47

 

​

26

 

​

94

 

​

2,187

(Loss) income before income tax (expense) benefit

 

​

(20)

 

​

473

 

​

(33)

 

​

(12)

 

​

217

 

​

(5)

 

​

(3)

 

​

(79)

 

​

538

Income tax (expense) benefit

 

​

—

 

​

(84)

 

​

12

 

​

(18)

 

​

—

 

​

—

 

​

—

 

​

(37)

 

​

(127)

Net (loss) income

 

​

(20)

 

​

389

 

​

(21)

 

​

(30)

 

​

217

 

​

(5)

 

​

(3)

 

​

(116)

 

​

411

Less: net (loss) income attributable to non-controlling interests

 

​

(4)

 

​

131

 

​

—

 

​

(3)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

124

Net (loss) income attributable to Icahn Enterprises

​

$

(16)

​

$

258

​

$

(21)

​

$

(27)

​

$

217

​

$

(5)

​

$

(3)

​

$

(116)

​

$

287

Supplemental information:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Capital expenditures

​

$

—

​

$

38

​

$

28

​

$

10

​

$

4

​

$

2

​

$

—

​

$

—

​

$

82

Depreciation and amortization

​

$

—

​

$

129

​

$

17

​

$

4

​

$

—

​

$

1

​

$

7

​

$

—

​

$

158

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 2024

​

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

​

​

(in millions)

Revenues:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net sales

​

$

—

​

$

1,834

​

$

216

​

$

101

​

$

6

​

$

47

​

$

27

​

$

—

​

$

2,231

Other revenues from operations

 

​

—

 

​

—

 

​

158

 

​

—

 

​

23

 

​

—

 

​

1

 

​

—

 

​

182

Net loss from investment activities

 

​

257

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

257

Interest and dividend income

 

​

77

 

​

10

 

​

1

 

​

—

 

​

1

 

​

—

 

​

—

 

​

26

 

​

115

Gain on disposition of assets, net

 

​

—

 

​

—

 

​

(1)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(1)

Other income, net

 

​

—

 

​

2

 

​

—

 

​

(1)

 

​

—

 

​

(3)

 

​

1

 

​

8

 

​

7

​

 

​

334

 

​

1,846

 

​

374

 

​

100

 

​

30

 

​

44

 

​

29

 

​

34

 

​

2,791

Expenses:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cost of goods sold

 

​

—

 

​

1,914

 

​

171

 

​

86

 

​

5

 

​

38

 

​

13

 

​

—

 

​

2,227

Other expenses from operations

 

​

—

 

​

—

 

​

133

 

​

—

 

​

18

 

​

—

 

​

—

 

​

—

 

​

151

Dividend expense

 

​

14

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

14

Selling, general and administrative

 

​

5

 

​

47

 

​

102

 

​

12

 

​

5

 

​

10

 

​

12

 

​

9

 

​

202

Interest expense

​

​

19

 

​

27

 

​

1

 

​

2

 

​

—

 

​

1

 

​

—

 

​

80

 

​

130

​

 

​

38

 

​

1,988

 

​

407

 

​

100

 

​

28

 

​

49

 

​

25

 

​

89

 

​

2,724

(Loss) income before income tax (expense) benefit

 

​

296

 

​

(142)

 

​

(33)

 

​

—

 

​

2

 

​

(5)

 

​

4

 

​

(55)

 

​

67

Income tax (expense) benefit

 

​

—

 

​

8

 

​

9

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(4)

 

​

13

Net (loss) income

 

​

296

 

​

(134)

 

​

(24)

 

​

—

 

​

2

 

​

(5)

 

​

4

 

​

(59)

 

​

80

Less: net (loss) income attributable to non-controlling interests

 

​

104

 

​

(46)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

58

Net (loss) income attributable to Icahn Enterprises

​

$

192

​

$

(88)

​

$

(24)

​

$

—

​

$

2

​

$

(5)

​

$

4

​

$

(59)

​

$

22

Supplemental information:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Capital expenditures

​

$

—

​

$

34

​

$

12

​

$

5

​

$

6

​

$

1

​

$

—

​

$

—

​

$

58

Depreciation and amortization

​

$

—

​

$

90

​

$

19

​

$

5

​

$

3

​

$

2

​

$

7

​

$

—

​

$

126

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nine Months Ended September 30, 2025

​

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

​

​

(in millions)

Revenues:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net sales

​

$

—

​

$

5,352

​

$

625

​

$

282

​

$

1

​

$

125

​

$

76

​

$

—

​

$

6,461

Other revenues from operations

 

​

—

 

​

—

 

​

461

 

​

—

 

​

44

 

​

—

 

​

3

 

​

—

 

​

508

Net loss from investment activities

 

​

(516)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(516)

Interest and dividend income

 

​

148

 

​

23

 

​

2

 

​

—

 

​

2

 

​

—

 

​

1

 

​

46

 

​

222

(Loss) gain on disposition of assets, net

 

​

—

 

​

(4)

 

​

(5)

 

​

—

 

​

271

 

​

—

 

​

—

 

​

—

 

​

262

Other income (loss), net

 

​

15

 

​

3

 

​

—

 

​

3

 

​

(1)

 

​

(1)

 

​

1

 

​

4

 

​

24

​

 

​

(353)

 

​

5,374

 

​

1,083

 

​

285

 

​

317

 

​

124

 

​

81

 

​

50

 

​

6,961

Expenses:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cost of goods sold

 

​

—

 

​

4,982

 

​

443

 

​

251

 

​

1

 

​

99

 

​

43

 

​

—

 

​

5,819

Other expenses from operations

 

​

—

 

​

—

 

​

411

 

​

—

 

​

44

 

​

—

 

​

—

 

​

—

 

​

455

Dividend expense

 

​

25

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

25

Selling, general and administrative

 

​

12

 

​

136

 

​

330

 

​

39

 

​

16

 

​

33

 

​

39

 

​

21

 

​

626

Impairment

​

​

—

​

​

—

​

​

—

​

​

12

​

​

—

​

​

—

​

​

—

​

​

—

​

​

12

Restructuring, net

​

​

—

​

​

—

​

​

—

​

​

7

​

​

—

​

​

—

​

​

—

​

​

—

​

​

7

Interest expense

 

​

14

 

​

101

 

​

2

 

​

8

 

​

—

 

​

1

 

​

—

 

​

253

 

​

379

​

 

​

51

 

​

5,219

 

​

1,186

 

​

317

 

​

61

 

​

133

 

​

82

 

​

274

 

​

7,323

(Loss) income before income tax benefit

 

​

(404)

 

​

155

 

​

(103)

 

​

(32)

 

​

256

 

​

(9)

 

​

(1)

 

​

(224)

 

​

(362)

Income tax benefit (expense)

 

​

—

 

​

15

 

​

30

 

​

(15)

 

​

—

 

​

—

 

​

—

 

​

(38)

 

​

(8)

Net (loss) income

 

​

(404)

 

​

170

 

​

(73)

 

​

(47)

 

​

256

 

​

(9)

 

​

(1)

 

​

(262)

 

​

(370)

Less: net (loss) income attributable to non-controlling interests

 

​

(148)

 

​

82

 

​

—

 

​

(4)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(70)

Net (loss) income attributable to Icahn Enterprises

​

$

(256)

​

$

88

​

$

(73)

​

$

(43)

​

$

256

​

$

(9)

​

$

(1)

​

$

(262)

​

$

(300)

Supplemental information:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Capital expenditures

​

$

—

​

$

130

​

$

74

​

$

26

​

$

29

​

$

7

​

$

—

​

$

—

​

$

266

Depreciation and amortization

​

$

—

​

$

307

​

$

51

​

$

14

​

$

11

​

$

4

​

$

21

​

$

—

​

$

408

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Nine Months Ended September 30, 2024

​

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

 

Consolidated

​

​

(in millions)

 

​

​

Revenues:

    

  

​

​

  

​

​

  

​

​

  

​

​

  

​

​

  

​

​

  

​

​

  

​

 

  

​

Net sales

​

$

—

​

$

5,663

​

$

665

​

$

307

​

$

17

​

$

127

​

$

76

​

$

—

​

$

6,855

Other revenues from operations

​

 

—

 

​

—

 

​

476

 

​

—

 

​

59

 

​

—

 

​

3

 

​

—

 

​

538

Net loss from investment activities

​

 

(318)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(318)

Interest and dividend income

​

 

269

 

​

30

 

​

3

 

​

—

 

​

1

 

​

—

 

​

1

 

​

76

 

​

380

Loss on disposition of assets, net

​

​

—

 

​

(1)

 

​

(5)

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(6)

Other income (loss), net

​

 

—

 

​

10

 

​

—

 

​

(3)

 

​

—

 

​

(3)

 

​

1

 

​

8

 

​

13

​

​

 

(49)

 

​

5,702

 

​

1,139

 

​

304

 

​

77

 

​

124

 

​

81

 

​

84

 

​

7,462

Expenses:

​

 

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cost of goods sold

​

 

—

 

​

5,549

 

​

473

 

​

252

 

​

13

 

​

98

 

​

41

 

​

—

 

​

6,426

Other expenses from operations

​

 

—

 

​

—

 

​

400

 

​

—

 

​

50

 

​

—

 

​

—

 

​

—

 

​

450

Dividend expense

​

 

47

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

—

 

​

47

Selling, general and administrative

​

 

15

 

​

124

 

​

303

 

​

36

 

​

14

 

​

31

 

​

32

 

​

23

 

​

578

Restructuring, net

​

 

—

 

​

—

 

​

—

 

​

1

 

​

—

 

​

—

 

​

—

 

​

—

 

​

1

Interest expense

​

 

63

 

​

86

 

​

2

 

​

8

 

​

—

 

​

1

 

​

—

 

​

234

 

​

394

​

​

 

125

 

​

5,759

 

​

1,178

 

​

297

 

​

77

 

​

130

 

​

73

 

​

257

 

​

7,896

(Loss) income before income tax (expense) benefit

​

 

(174)

 

​

(57)

 

​

(39)

 

​

7

 

​

—

 

​

(6)

 

​

8

 

​

(173)

 

​

(434)

Income tax (expense) benefit

​

 

—

 

​

26

 

​

13

 

​

(3)

 

​

—

 

​

—

 

​

—

 

​

(34)

 

​

2

Net (loss) income

​

 

(174)

 

​

(31)

 

​

(26)

 

​

4

 

​

—

 

​

(6)

 

​

8

 

​

(207)

 

​

(432)

Less: net (loss) income attributable to non-controlling interests

​

 

(86)

 

​

—

 

​

—

 

​

1

 

​

—

 

​

—

 

​

—

 

​

—

 

​

(85)

Net (loss) income attributable to Icahn Enterprises

​

$

(88)

​

$

(31)

​

$

(26)

​

$

3

​

$

—

​

$

(6)

​

$

8

​

$

(207)

​

$

(347)

Supplemental information:

​

 

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Capital expenditures

​

$

—

​

$

124

​

$

40

​

$

10

​

$

15

​

$

3

​

$

—

​

$

—

​

$

192

Depreciation and amortization

​

$

—

​

$

272

​

$

56

​

$

18

​

$

10

​

$

5

​

$

21

​

$

—

​

$

382

​

​

Disaggregation of Revenue

In addition to the condensed statements of operations by reporting segment above, we provide additional disaggregated revenue information for our Energy and Automotive segments below.

Energy

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 

​

Nine Months Ended September 30, 

​

    

2025

    

2024

    

2025

    

2024

​

​

(in millions)

Petroleum products

​

$

1,736

​

$

1,645

​

​

4,769

​

$

5,155

Renewable products

​

​

45

​

​

65

​

​

109

​

​

123

Nitrogen fertilizer products

​

 

164

​

 

124

​

 

474

​

 

385

​

​

$

1,945

​

$

1,834

​

$

5,352

​

$

5,663

​

Automotive

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 

​

Nine Months Ended September 30, 

​

    

2025

    

2024

    

2025

    

2024

​

​

(in millions)

Automotive Services

​

$

366

​

$

355

​

$

1,054

​

$

1,074

Aftermarket Parts

​

​

—

​

​

4

​

​

2

​

​

22

Total revenue from customers

​

$

366

​

$

359

​

​

1,056

​

​

1,096

Lease revenue outside the scope of ASC 606

​

​

8

​

​

15

​

​

30

​

​

45

Total Automotive net sales and other revenues from operations

​

$

374

​

$

374

​

$

1,086

​

$

1,141

​

Condensed Balance Sheets

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

September 30, 2025

​

​

Investment

​

Energy

​

Automotive

​

Food
Packaging

​

Real
Estate

​

Home
Fashion

​

Pharma

​

Holding
Company

​

Consolidated

​

​

(in millions)

ASSETS

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cash and cash equivalents

​

$

13

​

$

670

​

$

30

​

$

7

​

$

31

​

$

2

​

$

36

​

$

998

​

$

1,787

Cash held at consolidated affiliated partnerships and restricted cash

​

 

2,050

​

 

—

​

 

8

​

 

—

​

 

—

​

 

3

​

 

—

​

 

177

​

 

2,238

Investments

​

 

1,931

​

 

18

​

 

—

​

 

—

​

 

88

​

 

—

​

 

—

​

 

—

​

 

2,037

Accounts receivable, net

​

 

—

​

 

253

​

 

28

​

 

68

​

 

14

​

 

23

​

 

32

​

 

—

​

 

418

Related party note receivable

​

​

—

​

​

—

​

​

—

​

​

—

​

​

124

​

​

—

​

​

—

​

​

—

​

​

124

Inventories, net

​

 

—

​

 

509

​

 

170

​

 

92

​

 

—

​

 

96

​

 

25

​

 

—

​

 

892

Property, plant and equipment, net

​

 

—

​

 

2,401

​

 

815

​

 

133

​

 

334

​

 

56

​

 

—

​

 

3

​

 

3,742

Goodwill and intangible assets, net

​

 

—

​

 

144

​

 

322

​

 

21

​

 

—

​

 

22

​

 

149

​

 

—

​

 

658

Other assets

​

 

1,726

​

 

435

​

 

432

​

 

83

​

 

69

​

 

12

​

 

6

​

 

167

​

 

2,930

Total assets

​

$

5,720

​

$

4,430

​

$

1,805

​

$

404

​

$

660

​

$

214

​

$

248

​

$

1,345

​

$

14,826

LIABILITIES AND EQUITY

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

​

Accounts payable, accrued expenses and other liabilities

​

$

1,013

​

$

1,149

​

$

772

​

$

110

​

$

26

​

$

34

​

$

65

​

$

116

​

$

3,285

Securities sold, not yet purchased, at fair value

​

 

1,434

​

 

—

​

 

—

​

 

—

​

 

—

​

 

—

​

 

—

​

 

—

​

 

1,434

Debt

​

 

—

​

 

1,841

​

 

22

​

 

140

​

 

1

​

 

21

​

 

—

​

 

4,663

​

 

6,688

Total liabilities

​

 

2,447

​

 

2,990

​

 

794

​

 

250

​

 

27

​

 

55

​

 

65

​

 

4,779

​

 

11,407

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Equity attributable to Icahn Enterprises

​

 

2,449

​

 

807

​

 

1,011

​

 

142

​

 

633

​

 

159

​

 

183

​

 

(3,434)

​

 

1,950

Equity attributable to non-controlling interests

​

 

824

​

 

633

​

 

—

​

 

12

​

 

—

​

 

—

​

 

—

​

 

—

​

 

1,469

Total equity

​

 

3,273

​

 

1,440

​

 

1,011

​

 

154

​

 

633

​

 

159

​

 

183

​

 

(3,434)

​

 

3,419

Total liabilities and equity

​

$

5,720

​

$

4,430

​

$

1,805

​

$

404

​

$

660

​

$

214

​

$

248

​

$

1,345

​

$

14,826

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

December 31, 2024

​

​

Investment

​

Energy

​

Automotive

​

Food
Packaging

​

Real
Estate

​

Home
Fashion

​

Pharma

​

Holding
Company

​

Consolidated

​

​

(in millions)

ASSETS

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cash and cash equivalents

​

$

9

​

$

987

​

$

133

​

$

6

​

$

25

​

$

4

​

$

42

​

$

1,397

​

$

2,603

Cash held at consolidated affiliated partnerships and restricted cash

​

 

2,449

​

 

—

​

 

8

​

 

—

​

 

2

​

 

4

​

 

—

​

 

173

​

 

2,636

Investments

​

 

2,272

​

 

24

​

 

—

​

 

—

​

 

14

​

 

—

​

 

—

​

 

—

​

 

2,310

Accounts receivable, net

​

 

—

​

 

295

​

 

30

​

 

75

​

 

14

​

 

28

​

 

37

​

 

—

​

 

479

Inventories, net

​

 

—

​

 

502

​

 

168

​

 

109

​

 

—

​

 

93

​

 

25

​

 

—

​

 

897

Property, plant and equipment, net

​

 

—

​

 

2,504

​

 

808

​

 

124

​

 

350

​

 

53

​

 

—

​

 

4

​

 

3,843

Goodwill and intangible assets, net

​

 

—

​

 

159

​

 

328

​

 

21

​

 

—

​

 

19

​

 

170

​

 

—

​

 

697

Other assets

​

 

1,660

​

 

280

​

 

464

​

 

90

​

 

90

​

 

19

​

 

7

​

 

204

​

 

2,814

Total assets

​

$

6,390

​

$

4,751

​

$

1,939

​

$

425

​

$

495

​

$

220

​

$

281

​

$

1,778

​

$

16,279

LIABILITIES AND EQUITY

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

  

​

 

​

Accounts payable, accrued expenses and other liabilities

​

$

817

​

$

1,509

​

$

809

​

$

107

​

$

42

​

$

43

​

$

72

​

$

77

​

$

3,476

Securities sold, not yet purchased, at fair value

​

 

1,373

​

 

—

​

 

—

​

 

—

​

 

—

​

 

—

​

 

—

​

 

—

​

 

1,373

Debt

​

 

—

​

 

1,919

​

 

31

​

 

144

​

 

1

​

 

15

​

 

—

​

 

4,699

​

 

6,809

Total liabilities

​

 

2,190

​

 

3,428

​

 

840

​

 

251

​

 

43

​

 

58

​

 

72

​

 

4,776

​

 

11,658

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Equity attributable to Icahn Enterprises

​

 

2,703

​

 

685

​

 

1,099

​

 

159

​

 

447

​

 

162

​

 

209

​

 

(2,998)

​

 

2,466

Equity attributable to non-controlling interests

​

 

1,497

​

 

638

​

 

—

​

 

15

​

 

5

​

 

—

​

 

—

​

 

—

​

 

2,155

Total equity

​

 

4,200

​

 

1,323

​

 

1,099

​

 

174

​

 

452

​

 

162

​

 

209

​

 

(2,998)

​

 

4,621

Total liabilities and equity

​

$

6,390

​

$

4,751

​

$

1,939

​

$

425

​

$

495

​

$

220

​

$

281

​

$

1,778

​

$

16,279

​